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heavy vaginal bleeding causing anemia requiring a 7 unit packed red
blood cell transfusion and cervical biopsy conﬁrmed adenosquamous
carcinoma (Fig. 1A). She was treated as an inpatient with emergent ra-
diation. This was followed by cisplatin 40mg/m2 andwhole pelvic radi-
ation then tandem and ovoid intracavitary brachytherapy. The patient
was diagnosed with recurrent disease ﬁve months after the completion
of initial treatment. She had new retroperitoneal lymphadenopathy ex-
tending above the renal vessels outside of the radiated ﬁeld. She re-
ceived systemic therapy with 5 cycles of cisplatin 50 mg/m2 on day 1
and gemcitabine 800mg/m2 on days 1 and 8. She then received extend-ology, Department of Obstetric
iversity of Southern Californi
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. This is an open access article2Background
Worldwide, cervical cancer is the fourth most common type of
cancer in women and the most common gynecologic malignancy
(Ferlay et al., 2015). It is locally invasive spreading by direct exten-
sion in the pelvis and via lymphatic dissemination in retroperitoneal
lymph nodes. Hematogenous spread, the last and most rare route,
occurs in advanced disease with high-grade lesions, and can cause
distant metastases such as to the lungs, liver, and bone (Agarwal
et al., 2002). Less commonmetastatic disease sites have been report-
ed including distal skeletal sites such as the toe (Ciccone et al., 2014).
Here, we report a case of cervical cancer metastasized to the eye.
Given the rarity of eye metastasis, providers may not be aware of
this diagnosis and could inadvertently compromise quality of life
by delaying treatment.
Case
A 53-year-old woman with a known history of recurrent stage IIIB
adenosquamous carcinoma of the cervix undergoing treatment with
capecitabine 1000 mg twice daily presented with left eye pain. Hers
a,
undered ﬁeld radiation and a 9 Gy boost to her aorta-caval nodes. After treat-
ment, systemic imaging revealed new pulmonary metastasis. She was
given 9 cycles of paclitaxel at 80 mg/m given on days 1, 8 and 15. Her
lung metastasis progressed and she was started on capecitabine
1000 mg twice daily. One of her lung lesions was amenable to surgi-
cal resection and she underwent pulmonary wedge resection. The
pathology was consistent with metastatic squamous cell carcinoma.
It was within this postoperative period that she presented with eye
complaints.
Thirteen days after hermost recent normal clinical exam, the patient
reported a one day history of headaches and left eye pain. The patient
was evaluated at an emergency department outside of our institution
without intervention and discharged to home. She continued to have
symptoms upon her return to our clinic 2 weeks later. An urgent oph-
thalmology consult was placed. Nine days after this clinic visit, she pre-
sented to an outside hospital with worsening eye pain, and had brain
imaging that revealed a choroid metastasis and near total retinal de-
tachment (Fig. 2A–B). She was discharged with instructions to seek
care with an ophthalmologist at another facility. At our institution, the
patient was evaluated by an ophthalmologist; however, they deter-
mined that there was no role for radiation since there was no vision
to salvage. Given the painful symptoms that were negatively impacting
her quality of life, the ophthalmologist proceededwith enucleation and
orbital debulking of the lesion in the left eye. The procedure was un-
complicated. The pathology of the eye was consistent with a metastasis
of poorly differentiated carcinoma consistent with a cervical cancer pri-
mary to the choroid (Fig. 1B). The procedure occurred approximately
2 months after her initial eye symptoms. The patient then developed
rapid progression of disease including a 4 × 3 cm chest wall mass con-
sistentwithmetastasis at the port site of her prior lungwedge resection.
She was symptomatic with pain and underwent palliative radiation tothe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Histopathology study for cervical cancer. A) Hematoxylin and eosin staining (40×) for cervical biopsy at the time of cervical cancer diagnosis demonstrates poorly differentiated
squamous cell carcinoma, characterized by pleomorphism and high nuclear-to-cytoplasmic ratios. Geographic tumor necrosis was also seen in other areas (not shown).
B) Hematoxylin and eosin staining (20×) for right eye enucleation demonstrating metastatic poorly differentiated carcinoma with extensive necrosis.
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pice care. The patient died 5 months after her initial eye complaints.
Discussion
Metastatic tumors are the most common intraocular malignancy in
adults. They are most commonly found in the choroid and, to a much
lesser extent, in the iris and ciliary body (Shields et al., 2000). The poste-
rior choroid is particularly susceptible to hematogenous dissemination of
cancer cells due to its high vascularity. Breast and lung cancers comprise
two-thirds of the primary cancers with intraocular metastases (ShieldsFig. 2. Imaging study for ocular metastasis of cervical cancer. A) Cross-sectional view of headM
site in the left eye.et al., 2000). The majority of patients present with blurred vision and
pain, however, some are asymptomatic at the time of diagnosis
(Shields et al., 2000). Cervical cancerwas among themost rarely reported
primary cancers with intraocular metastases (Bloch and Gartner, 1971).
A systematic literature search was performed using PubMed/
MEDLINE on January 14th, 2015. The keywords “uveal or choroidal”
AND “cervix or cervical” AND “cancer or metastasis” produced 106 re-
sults which were screened by title and abstract, with 4 relevant case re-
ports found (Table 1). Three cases of cervical carcinomawithmetastases
to the choroid, two cases of squamous cell carcinoma (SCC) (Shibeeb
et al., 2014; Inoue et al., 2000) and one of adenocarcinoma (WiegelRI, and B) sagittal view of head CT scan imaging. Yellow arrow indicates orbital metastatic
Table 1
Summary of case reports of intraocular metastases from primary cervical cancer.
Author Shibeeb (Shibeeb et al., 2014) Inoue (Inoue et al., 2000) Wiegel (Wiegel et al., 1995) Kurosawa (Kurosawa and Sawaguchi, 1987) Uhrinaka
Year 2014 2000 1995 1971 2015
Ageb 52 55 25 54 53
Symptoms Progressive, painless
vision loss
Visual ﬁeld loss,
decreasing vision
Partial vision loss Decreased vision, pain,
and conjunctival hyperemia
Pain
Cancer stagec IVB IIIB IB IVB IIIB
Laterality Bilateral Bilateral Left Right Left
Intraocular met site Choroid Choroid Choroid Iris Choroid
Histology SCC SCC Adeno SCC SCC
Treatment External beam
radiotherapy
Radiotherapy, 36 Gy
to each eye
Radiotherapy, 40 Gy,
followed by chemotherapy
Radiotherapy, 30 Gy Enucleation and
orbital debulking
Survivald 3 months 3 months Unavailable ~3 months 5 months
Outcome DOD DOD Unavailable DOD DOD
Result of systematic review of literature is shown. Abbreviations: SCC, squamous cell carcinoma; Adeno, adenocarcinoma; met, metastatic; and DOD, died of disease.
a Current study.
b Age at ocular metastasis.
c Initial stage for cervical cancer.
d Survival time after ocular metastasis.
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(Kurosawa and Sawaguchi, 1987)were found. Themedian of 5 cases in-
cluding our experienced casewith eyemetastasis of cervical cancer was
53 (range, 25–55).
In a report by Shibeeb et al., they described the case of a 52-year-old
womanwith progressive and painless bilateral vision loss due to retinal
detachment in both the right and left eyes (Shibeeb et al., 2014). The pa-
tient was subsequently diagnosed with metastatic SCC of the cervix. Vi-
sual acuity improved after radiotherapy. In a report by Inoue et al., they
described the case of a 55-year-old woman who presented with vision
loss in her left eye with a previously diagnosed case of stage IIIB SCC
of the cervix (Inoue et al., 2000). She was subsequently diagnosed
with bilateral choroidal metastases with retinal detachment. After ra-
diotherapy to a total dose of 36 Gy in each eye, the retinal detachment
lessened. Wiegel et al. described the case of a 25-year-old pregnant
womanwith stage IB adenocarcinoma of the cervix who received initial
treatment of abortion and radical surgery (Wiegel et al., 1995). Two
years later, the patient developed retinal detachment in the left eye
and a solitary choroidal metastasis was diagnosed. The patient experi-
enced symptom relief with radiotherapy treatment and, 8 weeks fol-
lowing irradiation up to a total dose of 40 Gy, there was no detectable
metastatic tumor in the left eye. Kurosawa et al. described the case of
a 54-year-old woman with stage IVB SCC of the cervix who had under-
gone initial treatment with chemotherapy and irradiation (Kurosawa
and Sawaguchi, 1987). She presented 6months later with decreased vi-
sion, pain, and conjunctival hyperemia of the right eye and was diag-
nosed with metastatic SCC to the iris. She underwent radiotherapy up
to a total dose of 30 Gy with a decrease in symptoms.
According to Shields et al., treatment is prescribed to those patients
with symptomatic disease and/or a tumor that threatens visual acuity
(Shields et al., 2000). Of those who received treatment, the most com-
mon treatment remained external beam radiation or plaque radiation
over a short period of time (Shields et al., 2000). Speciﬁcally, visual acu-
ity may be improved with radiotherapy by decreasing the incidence of
retinal detachment secondary to the metastasis (Inoue et al., 2000). In
all three of the described cases with metastasis to the choroid, the pre-
senting symptomwas a decrease in visual acuity found to be secondary
to retinal detachment by choroidal metastases. All three patients were
treatedwith radiation and symptoms improved. The casewithmetasta-
sis to the iris resulted in decreased vision by the nodule causing focal
posterior synechia and localized cortical cataract. The size of the nodule
was reduced with radiotherapy (Kurosawa and Sawaguchi, 1987).
Three of the patients described in the case reports died only 3 months
after diagnosis (Shibeeb et al., 2014; Inoue et al., 2000; Kurosawa andSawaguchi, 1987), highlighting the advanced extent of disease leading
to hematogenous spread. Our patient died 5 months after her initial
eye complaints. Intraocular metastasis among all patients holds a life
expectancy of about 9 to 10 months (Shibeeb et al., 2014). One can as-
sume that the diagnosis of metastasis to the eye from a primary cervical
tumor is a poor prognostic indicator.
Although rare, when a woman presents with choroidal metastasis,
malignancy work up including cervical cancer should be included in
the differential diagnosis and diagnostic testing should include pelvic
imaging and a pelvic exam (Shields et al., 2000). In addition, when a
woman with known cervical cancer presents with complaints of de-
creased visual acuity, ophthalmologic consultation should be obtained
immediately to assess for intraocular metastasis.
In summary, our case demonstrates an unusual but possible site of
metastasis for cervical cancer. Providers should be aware that cervical
cancermaymetastasize to the eye and that swift intervention could sal-
vage vision in these patients. Although the presence of orbital metasta-
sis suggests rapidly progressing disease and shortened overall survival,
proper diagnosis and treatment of metastatic disease to the eye can im-
prove quality of life in these patients.Disclosure statement
The authors declare that there is no conﬂict of interest in the study.References
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